ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3030

Increased Localization of Spleen Tyrosine Kinase (Syk) in Lipid Rafts of in Vitro TCR/CD3-CD28 Activated Lupus T Cells

Noymar Luque1, Nursamaa Abdoel1, Héctor Rojas2, Martín Rodríguez1, Gloria Vásquez3 and Ana Blasini1, 1Centro Nacional de Enfermedades Reumáticas. Hospital Universitario de Caracas, Caracas, Venezuela, 2Instituto de Inmunología, Escuela de Medicina, Universidad Central de Venezuela, Caracas, Venezuela, 3Grupo de Inmunología Celular e Inmunogenética. Universidad de Antioquia, Medellin, Colombia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: SLE, SYK and T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: T cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Numerous alterations in signal transduction in SLE T cells have been previously reported.  Diminished expression of the ζ chain of  the TCR/CD3 complex has been shown to be accompanied by the substitutive assembly of  FcεRIγ chain and coupling to Syk PTK (Protein Tyrosine Kinase), rewiring downstream signaling to produce alternative functional outcomes in lupus T cells. Syk  is  100-fold   times enzymatically more potent than ZAP-70.  In this study we examined   the localization of ZAP-70 and Syk in lipid rafts of  lupus T cells; lipid raft is the site in membranes where signaling molecules preferentially associate to form signalosomes.       

Methods: SLE patients were diagnosed according to the American College of Rheumatology 1987 criteria.  Healthy donors were recruited from the blood bank of Hospital Universitario de Caracas.  All individuals signed an informed consent previously approved by the Hospital Bioethics Committee.  Highly enriched T cells, obtained from peripheral blood samples and subjected to RossetteSepTM  isolation, were adhered to poly-L-lysine coated slides and activated for 5 and 15 minutes at 37°C, with 4.5 μm superparamagnetic polystyrene beads coated with antibodies against CD3ε and CD28. The cells were fixed, permeabilized and stained with antibodies recognizing ZAP-70, Syk and Cholera Toxin Subunit B as a lipid raft marker. The cell-bead complexes were evaluated by confocal microscopy and densitometries were obtained using ImageJ, 1.49t (National Institutes of Health, USA).  

Results: We observed similar localization of Syk  in lipid rafts of unstimulated lupus  T cells as compared to healthy controls (0.216 ± 0.045 vs. 0.287 ± 0.056; Pearson’s  r  ± SME, n= 6).  In contrast, there was a diminished localization  of ZAP-70 in unstimulated lupus T cells  as compared to healthy controls (0.383 ± 0.035 vs. 0.488 ± 0.037; Pearson’s  r  ± SME, n= 6; Student’s t-test, p= 0.046,). After CD3-CD28 costimulation during 15 minutes, we observed an increased  localization of Syk in lipid rafts of lupus T cells  as compared  to healthy controls (0.352 ± 0.033 vs. 0.235 ± 0.042; Pearson’s  r    ± SME, n= 6; Student’s t-test, p= 0.034), whereas  ZAP-70 localization in lipid rafts after costimulation was similar in both groups (0.433 ± 0.040 vs. 0.402 ± 0.031; Pearson’s  r  ± SME, n= 6).     

Conclusion: Our findings suggest  an abnormal pattern in the localization of key tyrosine kinases in lipid rafts after activation of SLE T cells, with a predominant translocation of Syk over the typical T-cell kinase, ZAP-70. This abnormal response  may contribute to known signaling abnormalities such as displacement of transmembrane protein Linker for Activation of T cells (LAT)  from  lipid rafts and downstream deficient activation of Extracellular Signaling Regulated Kinases (ERK),   as previously shown in our laboratory.

Supported by Proyecto COLCIENCIAS contract No. 461-2012, code 1115-569-33414, and Proyecto FONACIT grant No. 2013000348.


Disclosure: N. Luque, None; N. Abdoel, None; H. Rojas, None; M. Rodríguez, None; G. Vásquez, None; A. Blasini, None.

To cite this abstract in AMA style:

Luque N, Abdoel N, Rojas H, Rodríguez M, Vásquez G, Blasini A. Increased Localization of Spleen Tyrosine Kinase (Syk) in Lipid Rafts of in Vitro TCR/CD3-CD28 Activated Lupus T Cells [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/increased-localization-of-spleen-tyrosine-kinase-syk-in-lipid-rafts-of-in-vitro-tcrcd3-cd28-activated-lupus-t-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-localization-of-spleen-tyrosine-kinase-syk-in-lipid-rafts-of-in-vitro-tcrcd3-cd28-activated-lupus-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology